About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
ESC Congress 2021: MASTER DAPT, ENVISAGE-TAVI AF and FIGARO-DKD Trials
By
American College of Cardiology
FEATURING
Deepak Bhatt
,
Philippe Gabriel Steg
February 15, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
09:22
Novo Nordisk – GLP-1 RA Therapy
GLP-1 RA as a First Injectable for T2D: What Is the Safety and Effic…
Feat.
R. Pratley
Featured Video
09:16
Novo Nordisk – GLP-1 RA Therapy
T2D Treatment After Metformin: What Does This GLP-1 RA Head-to-Head …
Feat.
R. Pratley
Related Content
AUTOPLAY
ON
08:43
Scottsdale Interventional Forum 2013
Debate: We Have Enough Information to Cut DAPT Down to 6 Months for …
Feat.
D. Rizik
08:25
Scottsdale Interventional Forum 2013
Debate: We Still Need More Data Before Cutting the Duration of DAPT …
Feat.
J. Hermiller
22:08
Scottsdale Interventional Forum 2013
Antithrombotic Pharmacology in ACS PCI: What’s Practical, What’s in …
Feat.
R. Harrington
17:19
Scottsdale Interventional Forum 2014
Essentials of ACS/PCI Pharmacology: An Overview and Approach
Feat.
R. Harrington
14:49
Scottsdale Interventional Forum 2014
The Big Ten: Pivotal Coronary Trials of the Last Year
Feat.
M. Parikh
41:22
Scottsdale Interventional Forum 2014
Friday Lunch - Conversations in Cardiology Featuring Morton J Kern
Feat.
M. Kern
16:55
Scottsdale Interventional Forum 2015
PCI Pharmacology in 2015: Choosing the Right Antiplatelet & Anti…
Feat.
S. Bailey
14:17
Scottsdale Interventional Forum 2015
Beyond ISAR Triple: Optimal Triple Drug Therapy After DES Implantati…
Feat.
M. Kutcher
21:27
ARCH Advanced Revascularization Symposium
Acute Coronary Syndromes
Feat.
R. Bach
19:24
San Diego Cardiovascular Interventions 2015
Contemporary Antithrombin and Antiplatelet Therapy for PCI
Feat.
W. Penny
22:38
Complex Interventional Cardiovascular Therapy (CICT) 2015
DAPT after coronary stenting should be extended beyond 12 months
Feat.
J. Messenger
20:25
Complex Interventional Cardiovascular Therapy (CICT) 2015
DAPT after coronary stenting should be limited to 6 months
13:15
Complex Cardiovascular Catheter Therapeutics (C3)
Pathophysiological Insights into Acute Coronary Syndrome by Optical …
Feat.
Y. Murasato
12:03
Complex Cardiovascular Catheter Therapeutics (C3)
What are the Major Pharmacodynamic and Safety Differences Between An…
Feat.
S. Nathan
24:35
Jeffrey Goldberger
Autonomic Control in Diabetes: Translational Perspective
12:55
Scottsdale Interventional Forum 2016
Update on PCI Pharmacology: What the Interventionalist needs to know…
Feat.
S. Bailey
40:18
ARCH Advanced Revascularization Symposium
Top Trials in Interventional Cardiology in 2015-2016
Feat.
J. Popma
15:31
ARCH Advanced Revascularization Symposium
Acute Coronary Syndrome Update
Feat.
R. Bach
21:52
Complex Coronary Valvular and Vascular Cases Conference
Optimal Duration of DAPT: Update on DAPT Guidelines
Feat.
R. Mehran
10:12
Complex Coronary Valvular and Vascular Cases Conference
Anti-Thrombotic Therapy for PCI
Feat.
D. Bhatt
